Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · IMMUNIC, INC. (IMUX)

Immunic director Duane Nash resigns; board reduced from ten to nine members

Neutral Impact 2 of 5 leadership Written later

Immunic director Dr. Duane Nash resigned from the Board of Directors on September 10, 2026. The company said the resignation was not due to any disagreement over its operations, policies, or practices, and the board reduced its size from ten members to nine.

Key points

  • Dr. Duane Nash resigned as a director on September 10, 2026.
  • The filing states no disagreement with the company on operations, policies, or practices.
  • Board size reduced from ten members to nine members.

The filing

CompanyIMMUNIC, INC. (IMUX)
Form8-K, current report
Filed with the SECSep 11, 2026, 5:24 PM ET
Accession number0001193805-26-001219

Items reported: 5.02 Director / Officer Change

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on September 11, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.